These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18404777)

  • 41. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity.
    Xie F; Zhao H; Zhao L; Lou L; Hu Y
    Bioorg Med Chem Lett; 2009 Jan; 19(1):275-8. PubMed ID: 19028425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.
    Zhang N; Wu B; Boschelli DH; Golas JM; Boschelli F
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5071-4. PubMed ID: 19632113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
    Kumar D; Patel G; Johnson EO; Shah K
    Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new series of diarylamides possessing quinoline nucleus: Synthesis, in vitro anticancer activities, and kinase inhibitory effect.
    El-Gamal MI; Khan MA; Abdel-Maksoud MS; Gamal El-Din MM; Oh CH
    Eur J Med Chem; 2014 Nov; 87():484-92. PubMed ID: 25282271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis of amide and urea derivatives of benzothiazole as Raf-1 inhibitor.
    Song EY; Kaur N; Park MY; Jin Y; Lee K; Kim G; Lee KY; Yang JS; Shin JH; Nam KY; No KT; Han G
    Eur J Med Chem; 2008 Jul; 43(7):1519-24. PubMed ID: 18023932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis, screening, and molecular modeling study of a new series of ROS1 receptor tyrosine kinase inhibitors.
    El-Deeb IM; Park BS; Jung SJ; Yoo KH; Oh CH; Cho SJ; Han DK; Lee JY; Lee SH
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5622-6. PubMed ID: 19700314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First Cdc7 kinase inhibitors: pyrrolopyridinones as potent and orally active antitumor agents. 2. Lead discovery.
    Menichincheri M; Bargiotti A; Berthelsen J; Bertrand JA; Bossi R; Ciavolella A; Cirla A; Cristiani C; Croci V; D'Alessio R; Fasolini M; Fiorentini F; Forte B; Isacchi A; Martina K; Molinari A; Montagnoli A; Orsini P; Orzi F; Pesenti E; Pezzetta D; Pillan A; Poggesi I; Roletto F; Scolaro A; Tatò M; Tibolla M; Valsasina B; Varasi M; Volpi D; Santocanale C; Vanotti E
    J Med Chem; 2009 Jan; 52(2):293-307. PubMed ID: 19115845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and in vitro cytotoxicity of 9-anilinoacridines bearing N-mustard residue on both anilino and acridine rings.
    Chen CH; Lin YW; Zhang X; Chou TC; Tsai TJ; Kapuriya N; Kakadiya R; Su TL
    Eur J Med Chem; 2009 Jul; 44(7):3056-9. PubMed ID: 18752869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and pp60c-Src tyrosine kinase inhibitory activities of novel indole-3-imine and amine derivatives substituted at N1 and C5.
    Kiliç Z; Isgör YG; Olgen S
    Arch Pharm (Weinheim); 2009 Jun; 342(6):333-43. PubMed ID: 19475593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and cytotoxicity of novel indirubin-5-carboxamides.
    Cheng X; Rasqué P; Vatter S; Merz KH; Eisenbrand G
    Bioorg Med Chem; 2010 Jun; 18(12):4509-15. PubMed ID: 20488718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of novel pyrrolopyrazoles as protein kinase C β II inhibitors.
    Li H; Hong Y; Nukui S; Lou J; Johnson S; Scales S; Botrous I; Tompkins E; Yin C; Zhou R; He M; Jensen J; Bouzida D; Alton G; Lafontaine J; Grant S
    Bioorg Med Chem Lett; 2011 Jan; 21(1):584-7. PubMed ID: 21084194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1 kinase inhibitors.
    Berger DM; Dutia M; Powell D; Floyd MB; Torres N; Mallon R; Wojciechowicz D; Kim S; Feldberg L; Collins K; Chaudhary I
    Bioorg Med Chem; 2008 Oct; 16(20):9202-11. PubMed ID: 18815050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and anti-tumor activities of novel methylthio-, sulfinyl-, and sulfonyl-8H-thieno[2,3-b]pyrrolizin-8-oximino derivatives.
    Guo S; Zhao Y; Zhao X; Zhang S; Xie L; Kong W; Gong P
    Arch Pharm (Weinheim); 2007 Aug; 340(8):416-23. PubMed ID: 17628032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and in-vitro antitumor activities of some mannich bases of 9-alkyl-1,2,3,4-tetrahydrocarbazole-1-ones.
    Chen J; Lou J; Liu T; Wu R; Dong X; He Q; Yang B; Hu Y
    Arch Pharm (Weinheim); 2009 Mar; 342(3):165-72. PubMed ID: 19212985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel trans-dichloridoplatinum(II) complexes with 3- and 4-acetylpyridine: Synthesis, characterization, DFT calculations and cytotoxicity.
    Rakić GM; Grgurić-Sipka S; Kaluderović GN; Gómez-Ruiz S; Bjelogrlić SK; Radulović SS; Tesić ZLj
    Eur J Med Chem; 2009 May; 44(5):1921-5. PubMed ID: 19070943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer.
    Wickens P; Kluender H; Dixon J; Brennan C; Achebe F; Bacchiocchi A; Bankston D; Bierer D; Brands M; Braun D; Brown MS; Chuang CY; Dumas J; Enyedy I; Hofilena G; Hong Z; Housley T; Jones B; Khire U; Kreiman C; Kumarasinghe E; Lowinger T; Ott-Morgan R; Perkins L; Phillips B; Schoenleber R; Scott WJ; Sheeler R; Redman A; Sun X; Taylor I; Wang L; Wilhelm S; Zhang X; Zhang M; Sullivan E; Carter C; Miglarese M; Levy J
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4378-81. PubMed ID: 17574417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: design, synthesis and potential antitumor activity.
    Wu A; Xu Y; Qian X
    Bioorg Med Chem; 2009 Jan; 17(2):592-9. PubMed ID: 19109022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells.
    Banti I; Nencetti S; Orlandini E; Lapucci A; Breschi MC; Fogli S
    J Pharm Pharmacol; 2009 Aug; 61(8):1057-66. PubMed ID: 19703350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
    Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
    Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins.
    Akue-Gedu R; Debiton E; Ferandin Y; Meijer L; Prudhomme M; Anizon F; Moreau P
    Bioorg Med Chem; 2009 Jul; 17(13):4420-4. PubMed ID: 19477650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.